ArticleJAMA network open2023
Factors Associated With Public Trust in Pharmaceutical Manufacturers.
Article in JAMA network open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- [Associated factors with vaccine hesitancy in sub-Saharan Africa: a literature review].The Pan African medical journal · 2026Pooled it
- Traditional, Complementary, and Integrative Medicine on X (Formerly Twitter) From 2015 to 2024 Across English, Spanish, and French: Retrospective Observational Study.Journal of medical Internet research · 2026Observational
- Patient Perceptions on the Use of Artificial Intelligence in Creating Clinical Research Documents: Survey Study.JMIR AI · 2026Article
- Determinants of antibiotics misuse and overuse in high-risk countries in the European region: a multidisciplinary Delphi study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- (Mis)trust among patients seeking unproven stem cell therapies: a qualitative analysis.Frontiers in medicine · 2026Article
- Mapping the path to diversity in clinical trials: a qualitative study of community member and stakeholder perspectives.BMC public health · 2025Article
- Understanding public confidence in locally-produced mRNA vaccines: Insights for future pandemic preparedness.Human vaccines & immunotherapeutics · 2025Article
- Embracing Medicines Development as a Profession.Pharmaceutical medicine · 2025Review
- Promoting Diversity through an Understanding of Barriers and Drivers for Inclusive Clinical Trials.Therapeutic innovation & regulatory science · 2025Article
- Evolving demographics of eligible patient population can impact enrollment of a biomarker clinical study.PloS one · 2025Article
- Determinants of COVID-19 Vaccine Hesitancy: A Cross-Sectional Study in Three Communities in the United States and Lebanon.Microorganisms · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.